667 results on '"Freedman, Arnold"'
Search Results
2. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
3. Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia
4. Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
5. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
6. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
7. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
8. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
9. Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study
10. Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
11. Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
12. Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
13. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
14. Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma
15. Non‐Hodgkin's Lymphoma
16. Follicular lymphoma: 2018 update on diagnosis and management
17. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma
18. Low-Dose Involved-Field Radiation in the Treatment of Non-Hodgkin Lymphoma: Predictors of Response and Treatment Failure
19. Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma
20. Predictive Factors for Radiation Pneumonitis in Hodgkin Lymphoma Patients Receiving Combined-Modality Therapy
21. A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma
22. Cell Surface Markers in Leukemia and Lymphoma
23. B-Cell Function and Ontogeny
24. Prognostic Value of Minimal Residual Disease (MRD) Among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation
25. Adhesion of Human B Cells to Germinal Centers in Vitro Involves VLA-4 and INCAM-110
26. Expression and State of Phosphorylation of the Retinoblastoma Susceptibility Gene Product in Cycling and Noncycling Human Hematopoietic Cells
27. B-Cell Surface Antigen B7 Provides a Costimulatory Signal That Induces T Cells to Proliferate and Secrete Interleukin 2
28. Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma
29. Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome
30. Follicular lymphoma: 2014 update on diagnosis and management
31. Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma
32. Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma
33. Long-Term Survival after Autologous Bone Marrow Transplantation for Follicular Lymphoma in First Remission
34. Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses
35. Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
36. Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era
37. Non–Transplant-Related Treatment Options in Follicular Lymphoma
38. Follicular lymphoma: 2012 update on diagnosis and management
39. Primary bone lymphoma involving bilateral tibia
40. Telescopic Retainers: An Old or New Solution? A Second Chance to Have Normal Dental Function
41. Follicular lymphoma: 2011 update on diagnosis and management
42. Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations
43. A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay
44. Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy
45. Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma
46. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization
47. Follicular lymphoma: 2020 update on diagnosis and management
48. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
49. A 60-year-old woman with epidural and paraspinal masses
50. Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.